Abstract:Epilepsy is a complex and multifaceted neurological disorder characterized by spontaneous and recurring seizures. It poses significant therapeutic challenges due to its diverse etiology and often-refractory nature. This comprehensive review highlights the pivotal role of AMP-activated protein kinase (AMPK), a key metabolic regulator involved in cellular energy homeostasis, which may be a promising therapeutic target for epilepsy. Current therapeutic strategies such as antiseizure medication (ASMs) can alleviate seizures (up to 70%). However, 30% of epileptic patients may develop refractory epilepsy. Due to the complicated nature of refractory epilepsy, other treatment options such as ketogenic dieting, adjunctive therapy, and in limited cases, surgical interventions are employed. These therapy options are only suitable for a select group of patients and have limitations of their own. Current treatment options for epilepsy need to be improved. Emerging evidence underscores a potential association between impaired AMPK functionality in the brain and the onset of epilepsy, prompting an in-depth examination of AMPK’s influence on neural excitability and ion channel regulation, both critical factors implicated in epileptic seizures. AMPK activation through agents such as metformin has shown promising antiepileptic effects in various preclinical and clinical settings. These effects are primarily mediated through the inhibition of the mTOR signaling pathway, activation of the AMPK-PI3K-c-Jun pathway, and stimulation of the PGC-1α pathway. Despite the potential of AMPK-targeted therapies, several aspects warrant further exploration, including the detailed mechanisms of AMPK’s role in different brain regions, the impact of AMPK under various conditional circumstances such as neural injury and zinc toxicity, the long-term safety and efficacy of chronic metformin use in epilepsy treatment, and the potential benefits of combination therapy involving AMPK activators. Moreover, the efficacy of AMPK activators in refractory epilepsy remains an open question. This review sets the stage for further research with the aim of enhancing our understanding of the role of AMPK in epilepsy, potentially leading to the development of more effective, AMPK-targeted therapeutic strategies for this challenging and debilitating disorder.

The Role of Sequestosome 1/p62 Protein in Epilepsy

Role of the Mtor Signaling Pathway in Epilepsy

Pervasive expostulation of p53 gene promoting the precipitation of neurogenic convulsions: A journey in therapeutic advancements

A Purinergic P2 Receptor Family-Mediated Increase in Thrombospondin-1 Bolsters Synaptic Density and Epileptic Seizure Activity in the Amygdala-Kindling Rat Model

Phosphatidylinositol 3-Kinase/protein Kinase B/mammalian Target of Rapamycin Signaling Pathway and Epilepsy

The role of sequestosome 1/p62 protein in amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis

From autophagy to mitophagy: the roles of P62 in neurodegenerative diseases

Sequestosome 1/p62: A multitasker in the regulation of malignant tumor aggression (Review)

The microRNA-211-5p/P2RX7/ERK/GPX4 axis regulates epilepsy-associated neuronal ferroptosis and oxidative stress

Pharmacological modulation of autophagy for epilepsy therapy: opportunities and obstacles

P62/sqstm1, a Central but Unexploited Target: Advances in Its Physiological/Pathogenic Functions and Small Molecular Modulators.

Beclin1 Deficiency Suppresses Epileptic Seizures

Recent Progress in Identifying Genetic and Epigenetic Contributions to Epilepsy

The Role of HIF-1α/HO-1 Pathway in Hippocampal Neuronal Ferroptosis in Epilepsy

Neuronal Nitric Oxide Synthase/reactive Oxygen Species Pathway is Involved in Apoptosis and Pyroptosis in Epilepsy

Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy

AMPK role in epilepsy: a promising therapeutic target?

Insights into Human Epileptogenesis with Proteomic Profiling

Proteomic Differences in the Hippocampus and Cortex of Epilepsy Brain Tissue

The Homeostasis of p62/SQSTM1 Short Isoform Regulates Selective Autophagy

Diagnostic and therapeutic value of P2Y12R in epilepsy